Weight-loss drugs impact food sales
Japanese food on plates (Scopio from Noun Project)
The rising popularity of weight-loss drugs such as Ozempic and Wegovy is changing people’s food shopping habits.
In the US, Wallmart supermarkets have noticed that customers that use appetite-suppressing drugs such as Ozempic and Wegovy are buying fewer food items and consuming fewer calories, reports Bloomberg.
Ozempic and Wegovy have become hugely popular as more people are using them as studies have shown they have positive effects for treating diabetes and losing weight.
The Danish company that makes the two drugs, Novo Nordisk, is struggling to produce enough Ozempic and Wegovy to meet demand.
so what?
The rise of such drugs could have a wider impact on society and people’s lifestyles. More and more CEOs from different sectors are looking at how the likes of Ozempic and Wegovy can affect business, reports Bloomberg.
British bank Barclays wrote in a recent investment report that sales of companies that produce potato chips and fast food could suffer because of the rise of appetite-suppressing drugs.
Barclays considers the rise of weight-loss drugs is up there with artificial intelligence on the list of major trends to keep an eye on in coming years. 
Reference shelf:
Ozempic Is Making People Buy Less Food, Walmart Says (Bloomberg)
How an Obession With Self-Care Paved The Way for Ozempic (Rolling Stone)
Short Fast Food Credit Because of Ozempic, Barclays Says (Bloomberg)
More by WONKedition:As streaming grows we take longer to find what to watch
